Dudediligence.

Eloxx Pharmaceuticals, Inc

ELOXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: S-1, Registration of sharesSep 11 →InsidersNo open-market buys or sales.→HoldersNantahala 19.8%Samsara Biocapital 9.9%Aberdeen 9.9%→Financing →PeersClosest companies: PRAX, TYRA, CGEM→

From the filings

Figures

Revenue
$0.00last 12 months
Net income
−$8.0Mlast 12 months
Operating cash flow
−$13.0Mlast 12 months
Cash and equivalents
$62.0Mat the last balance sheet
Total debt
$0.00at the last balance sheet
Shares outstanding
4.0M shareson issue
Every year and quarter →